GEORGE PERRY, PhD

based in San Antonio, Texas

Our studies are focused on the cytopathology and physiology of oxidative stress. We have shown that oxidative damage is the initial neurodegenerative cytopathological abnormality in Alzheimer disease. We are working to determine the sequence of events leading to neuronal oxidative damage and the source of the increased oxygen radicals. Our current studies focus on two issues: i) the metabolic basis for the mitochondrial damage restricted to vulnerable neurons; and ii) the consequences of RNA oxidation on protein synthesis rate and fidelity.

Dr. Perry also serves as Editor-in-Chief (together with Mark A. Smith) for the Journal of Alzheimer's Disease.

Key words: doping, anti-doping, blood-doping, uptake, transport or delivery of oxygen, oxygen radicals, oxidative stress, protein modification, RNA, placebo effect, ethics, behavioral aspects of doping, gene doping.

Dr. Perry articles at PubMed | Dr.Perry Institutional web page | Dr.Perry email contact